MagVenture Inc., a provider of transcranial magnetic stimulation, has received clearance from the US Food and Drug Administration for a new protocol that cuts the time of each treatment session down to 3 minutes, the company announced.
Teenage girls are twice as likely as boys to show depressive symptoms linked to social media use - mainly due to online harassment and disturbed sleep, as well as poor body image and lower self-esteem, researchers have found.
Anxiety and depression are as predictive of poor physical health as obesity and smoking are and, consequently, should be better addressed during routine visits to primary care providers, suggests a study published online in Health Psychology.
In abstinence-motivated people with opioid dependence, symptoms of anxiety, depression or insomnia should not prevent switching from an opioid agonist to extended-release naltrexone (XR-NTX), researchers in Norway say.
The year's most-read stories include ketamine as a maintenance treatment for anxiety and the most effective atypicals in bipolar depression.
The year's most-read depression-related topics: The effects of cannabis, a possible breakthrough drug, and a new generation of treatment approaches.
BLOG: On January 18, 2018, in Sacramento California, new mother Jessica Porten went to see a women’s health nurse practitioner. She was 4 months postpartum and had not been seen by her obstetric provider since giving birth.
BLOG: Recent qualitative studies on subjects treated with psilocybin may begin to help us understand the subjective experience caused by the drug that may lead to its antidepressant effects.
BLOG: We psychiatrists read so much about physicians being “difficult patients.” What about when the shoe is on the other foot?